- Advertisement -

StockWatch: Investors Unfazed by Biogen CEO Search, Aduhelm Cutbacks

Stay at the forefront of the week’s champions and runners-up among publicly traded biotech companies and the reasons behind the ups or downs of...

Toxic Compound Gives C. difficile Competitive Advantage in Infected Gut

The pathogen Clostridioides difficile (C. difficile) is the most common cause of healthcare-associated infectious diarrhea. A team led by investigators at Vanderbilt University Medical...

Bharat Biotech – COVAXIN™

Candidate: COVAXIN Category: VAX Type: Inactivated SARS-CoV-2 vaccine with alum as adjuvant Status: COVAXIN could be launched as early as February 2021, months ahead of schedule, based on the...

Superpowered Cell Therapies: The Role of Single-Cell Proteomics

View eBook  Chimeric Antigen Receptor (CAR)-T cell therapy and other cell therapies have made great advancements in fighting cancer in recent years, but several challenges...

Researchers develop antibody drugs from tobacco plants for cancer treatment

For the first time in Thailand, lecturers at Chulalongkorn University's Faculty of Pharmaceutical Sciences have successfully developed antibody from tobacco plants with inhibitory effects...

Commercial Seeds (Conventional, Biotechnology) Market Report 2020: Global Methodology, Research Findings,...

A detailed research study on the Commercial Seeds (Conventional, Biotechnology) Market was recently published by DataIntelo. This is a latest report, covering the current...

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone...

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million...

BioTrinity 2026 Showcases Delivery Technologies and Promising Therapeutic Candidates

European biotechs presented a range of interesting technologies and novel therapeutic biotechs at the recent BioTrinity conference, organized by BioUK, formerly OBN. The meeting...

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million...

BioTrinity 2026 Showcases Delivery Technologies and Promising Therapeutic Candidates

European biotechs presented a range of interesting technologies and novel therapeutic biotechs at the recent BioTrinity conference, organized by BioUK, formerly OBN. The meeting...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

more new items

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone...

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million...

BioTrinity 2026 Showcases Delivery Technologies and Promising Therapeutic Candidates

European biotechs presented a range of interesting technologies and novel therapeutic biotechs at the recent BioTrinity conference, organized by BioUK, formerly OBN. The meeting...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...